TransCode Therapeutics, Inc. (RNAZ) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 23.94K | 0 | 4.78K | 0 | 0 | 0 | 127.52K | 0 | 0 | 140.17K | 138.78K | 137.59K | 100.2K | 29.5K | 24.8K | 22.7K | 21.6K | 28.99K | 7.54K | 4.69K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -23.94K | 0 | -4.78K | 0 | 0 | 0 | -127.52K | 0 | 0 | -140.17K | -138.78K | -137.59K | -100.2K | -29.5K | -24.8K | -22.7K | -21.6K | -28.99K | -7.54K | -4.69K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | 96.25% | - | - | 100% | 8.11% | 100% | 100% | -375.08% | -459.56% | -506.18% | -363.86% | -1.78% | -229.16% | -383.76% | -1621.2% | - | - | - |
| Operating Expenses | 7.3M | 16.03M | 4.56M | 4.22M | 3.17M | 5.09M | 2.04M | 5.11M | 3.29M | 3.92M | 5.19M | 4.99M | 4.8M | 5.5M | 4.93M | 4.68M | 3.46M | 2.96M | 2.35M | 350.84K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.22B | 1.76M | 1.4M | 1.66M | 951.65K | 1.45M | 826.54K | 2.03M | 1.53M | 555.24K | 1.85M | 2.03M | 2.21M | 2.84M | 1.91M | 2.06M | 1.57M | 1.67M | 1.36M | 139.08K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 5.11B | 5.48M | 3.16M | 2.57M | 2.22M | 3.64M | 1.21M | 3.08M | 1.76M | 3.36M | 3.34M | 2.97M | 2.59M | 2.66M | 3.02M | 2.62M | 1.88M | 1.29M | 992.95K | 211.75K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.33M | -16.03M | -4.56M | -4.22M | -3.17M | -5.09M | -2.17M | -5.11M | -3.29M | -4.06M | -5.33M | -5.13M | -4.9M | -5.53M | -4.95M | -4.71M | -3.48M | -2.99M | -2.36M | -355.53K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -131.11% | -214.72% | -110.64% | 17.46% | 3.58% | -25.46% | 59.35% | 0.33% | 32.89% | 26.57% | -7.55% | -9% | -40.94% | -85.1% | -109.9% | -1224.03% | -673.7% | -687.92% | -885.39% | - |
| EBITDA | -7.3M | -15.98M | -4.56M | -4.21M | -3.12M | -4.97M | -2.04M | -4.97M | -3.15M | -3.92M | -5.19M | -4.99M | -4.8M | -5.5M | -4.93M | -4.68M | -3.46M | -2.96M | -2.35M | -350.84K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -134.13% | -221.6% | -123.58% | 15.36% | 0.87% | -26.81% | 60.72% | 0.44% | 34.44% | 28.72% | -5.27% | -6.59% | -38.92% | -85.91% | -109.52% | -1235.27% | -671.04% | -295.53% | -115.1% | - |
| D&A (Non-Cash Add-back) | 23.94K | 44.78K | 4.78K | 13.44K | 51.17K | 122.86K | 127.52K | 142.83K | 141.65K | 140.17K | 138.78K | 137.59K | 100.2K | 29.5K | 24.8K | 22.7K | 21.6K | 28.99K | 7.54K | 4.69K |
| EBIT | -7.33M | -13.22M | -4.85M | -4.28M | -12.09M | -5.91M | -2.31M | -5.19M | -3.32M | -4.03M | -5.3M | -4.34M | -4.82M | -5.13M | -4.29M | -4.67M | -3.47M | -2.8M | -2.33M | 2.81M |
| Net Interest Income | 91.89K | 78.22K | -5.81K | 148 | 32 | -1.67K | -10.61K | -4.3K | -9.54K | -55.76K | 131 | -7.6K | -8.66K | 9.64K | 9K | 1.33K | 442 | 510 | -192 | -41.97K |
| Interest Income | 91.89K | 78.76K | 147 | 148 | 146 | 159 | 179 | 178 | 168 | 137 | 131 | 246 | 4.77K | 9.64K | 9K | 1.33K | 442 | 510 | 141 | 0 |
| Interest Expense | 0 | 542 | 5.96K | 0 | 114 | 1.83K | 10.79K | 4.48K | 9.71K | 55.9K | 0 | 7.84K | 13.43K | 0 | 0 | 0 | 0 | 0 | 333 | 41.97K |
| Other Income/Expense | -10.22M | 2.81M | -294.85K | -55.37K | -8.91M | -823.57K | -155.97K | -76.9K | -37.83K | -28.51K | 27.57K | 789.18K | 84.18K | 393.4K | 663.95K | 36.06K | 7.43K | 186.97K | 30.2K | 3.13M |
| Pretax Income | -17.55M | -13.22M | -4.86M | -4.28M | -12.09M | -5.92M | -2.32M | -5.19M | -3.33M | -4.09M | -5.3M | -4.34M | -4.82M | -5.13M | -4.29M | -4.67M | -3.47M | -2.8M | -2.33M | 2.77M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 231.31K | 226.07K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -1.32% | -1.71% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -17.79M | -13.44M | -4.86M | -4.28M | -12.09M | -5.92M | -2.32M | -5.19M | -3.33M | -4.09M | -5.3M | -4.34M | -4.82M | -5.13M | -4.29M | -4.67M | -3.47M | -2.8M | -2.33M | 2.77M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -47.16% | -127.23% | -109.19% | 17.61% | -263.27% | -44.73% | 56.2% | -19.56% | 30.94% | 20.38% | -23.55% | 7.06% | -38.81% | -83.41% | -84.13% | -268.58% | 22.64% | -249.24% | -69.57% | - |
| Net Income (Continuing) | -17.79M | -13.44M | -4.86M | -4.28M | -12.09M | -5.92M | -2.32M | -5.19M | -3.33M | -4.09M | -5.3M | -4.34M | -4.82M | -5.13M | -4.29M | -4.67M | -3.47M | -2.8M | -2.33M | 2.77M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -21.28 | -16.42 | -5.82 | -5.13 | -70.28 | -16.61 | 15.34 | -24.42 | -21.45 | -761.16 | -48.44 | -142.38 | -259.07 | -37828.08 | -264.40 | -288.00 | -216.00 | -18256.57 | -160.00 | 185.25 |
| EPS Growth % | 69.72% | 1.14% | -137.94% | 78.99% | -227.65% | 97.82% | 131.67% | 82.85% | 91.72% | 97.99% | 81.68% | 50.56% | -19.94% | -107.2% | -65.25% | -255.47% | 28.02% | -445.22% | 7.08% | - |
| EPS (Basic) | -21.28 | -16.42 | -5.82 | -5.13 | -70.28 | -16.61 | 15.34 | -24.42 | -21.45 | -761.16 | -48.44 | -142.38 | -259.07 | -37828.08 | -264.40 | -288.00 | -216.00 | -18404.90 | -160.00 | 185.25 |
| Diluted Shares Outstanding | 916.97K | 916.97K | 833.68K | 833.65K | 172.26K | 356.12K | 356.12K | 213.67K | 155.83K | 5.37K | 109.41K | 30.49K | 18.59K | 487 | 16.22K | 16.22K | 16.22K | 484 | 14.41K | 14.96K |
| Basic Shares Outstanding | 916.97K | 916.97K | 833.68K | 833.65K | 172.26K | 356.12K | 356.12K | 213.67K | 155.83K | 5.37K | 109.41K | 30.49K | 18.59K | 487 | 16.22K | 16.22K | 16.22K | 480 | 14.41K | 14.96K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |